Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02605499
Other study ID # IRB00063160
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 2015
Est. completion date February 2018

Study information

Verified date September 2018
Source Johns Hopkins University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study examines the impact of UV-C light disinfection as an adjunct to routine daily and discharge patient room cleaning on patient infection and colonization with hospital associated bacteria.

Patient rooms are counted as enrolled since consent was waived and the number of participants is unknown. Total of 83 rooms.


Description:

Effective cleaning of the patient environment (the patient room during hospital stay) is subject to human factors and unfortunately is often inconsistent or inadequate. Patient rooms that have residual bacteria after routine environmental cleaning can act as reservoirs for multidrug-resistant organisms (MDROs) and contribute to the spread of MDROs from patient to patient. In the setting of an increased focus on Healthcare-associated Infections such as Clostridium difficile (C. difficile) and multidrug-resistant Gram negative and Gram positive organisms such as carbapenem-resistant Enterobacteriaceae (CRE), vancomycin-resistant Enterococcus (VRE) and methicillin-resistant Staphlococcus aureus (MRSA), Ultra-Violet C (UV-C) light has been shown to be a safe, effective way to decrease the burden of MDROs in patient rooms. However, studies examining the effectiveness of UV-C light when used post daily and discharge patient room cleaning are lacking.

This study is a cluster, randomized, two-period cross over trial to investigate the relationship between environmental decontamination with UV-C light and transmission of VRE and other healthcare-associated bacteria. It investigates the hypothesis that UV-C in addition to daily cleaning leads to decreased patient acquisition of healthcare-associated bacteria.

This study is important to further advance hospital-based infection prevention knowledge of the impact of UV-C light for environmental cleaning.

Patient rooms are counted as enrolled since consent was waived and the number of participants is unknown. Total of 83 rooms.


Recruitment information / eligibility

Status Completed
Enrollment 83
Est. completion date February 2018
Est. primary completion date February 2018
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria:

- Patient rooms in pre-selected hospital units within Johns Hopkins Hospital

Exclusion Criteria:

- None, intervention is at level of the hospital unit, not the patient

Study Design


Intervention

Other:
UV-C light disinfection
UV-C light disinfection will be used in hospital patient rooms as an adjunct to routine daily and discharge cleaning.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Johns Hopkins University

Outcome

Type Measure Description Time frame Safety issue
Primary Acquisition of Vancomycin Resistant Enterococcus Rates of Vancomycin Resistant Enterococcus acquisition will be compared between intervention and control periods. 2 years
Primary Acquisition of a composite rate of healthcare-associated bacteria: Vancomycin Resistant Enterococcus, Methicillin Resistant Staphylococcus Aureus, hospital-onset bacteremias, Clostridium difficile, and central line associated bloodstream infections. Rates of Vancomycin Resistant Enterococcus, Methicillin Resistant Staphylococcus Aureus, hospital-onset bacteremias, multidrug resistant gram negative bacteria, Clostridium difficile, and central line associated bloodstream infections will be compared between intervention and control periods. 2 years
Secondary Acquisition of Vancomycin Resistant Enterococcus (clinical infection) Rates of Vancomycin Resistant Enterococcus acquisition (clinical infection) will be compared between intervention and control periods. 2 years
Secondary Acquisition of Vancomycin Resistant Enterococcus (colonization) Rates of Vancomycin Resistant Enterococcus acquisition (colonization) will be compared between intervention and control periods. 2 years
Secondary Acquisition of Clostridium difficile (infection) Rates of Clostridium difficile infection will be compared between intervention and control periods. 2 years
Secondary Acquisition of Clostridium difficile (colonization or infection) Rates of Clostridium difficile (colonization or infection) will be compared between the intervention and control arms. 2 years
Secondary Acquisition of bacteremia Rates of hospital onset bacteremia will be compared between the intervention and control arms. 2 years
Secondary Acquisition of Methicillin Resistant Staphylococcus Aureus (clinical) Rates of Methicillin Resistant Staphylococcus Aureus acquisition (clinical infection) will be compared between intervention and control periods. 2 years
Secondary Acquisition of Methicillin Resistant Staphylococcus Aureus (colonization) Rates of Methicillin Resistant Staphylococcus Aureus acquisition (colonization) will be compared between intervention and control periods. 2 years
Secondary Acquisition of Methicillin Resistant Staphylococcus Aureus (clinical or colonization) Rates of Methicillin Resistant Staphylococcus Aureus acquisition (clinical or colonization) will be compared between intervention and control periods. 2 years
Secondary Acquisition of Central line associated bloodstream infections Rates of Central line associated bloodstream infections in intervention and control arms will be compared. 2 years
Secondary Acquisition of multidrug resistant gram negative bacteria (colonization) Rates of multidrug resistant gram negative bacteria acquisition (colonization) will be compared between intervention and control periods. 2 years
Secondary Acquisition of multidrug resistant gram negative bacteria Rates of multidrug resistant gram negative bacteria acquisition will be compared between intervention and control periods. 2 years
Secondary Differences in patient overall satisfaction with hospital stay as assessed by the Hospital Consumer Assessment of Healthcare Providers and Systems Survey. Patient satisfaction with overall hospital stay will be compared between intervention and control arms. 2 years
Secondary Differences in patient satisfaction with environmental cleaning as assessed by the Hospital Consumer Assessment of Healthcare Providers and Systems Survey. Patient satisfaction with environmental cleaning will be compared between intervention and control arms. 2 years
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04976829 - Evaluating Antibiotic Stewardship Assisted by Computer in the University Hospital of Nancy (MACABAO)
Recruiting NCT05589727 - Application of Ventilator-Associated Events (VAE) in Ventilator-Associated Pneumonia (VAP) Notified in Brazil
Completed NCT04873557 - Copper Use as Protection Against Antimicrobial Resistance in the ICU N/A
Completed NCT03843021 - Ventricular Assist Device (VAD) Infection Prevention Survey
Recruiting NCT04579094 - Prevalence and Risk Factors for the Carriage of Bacteria and Clostridioid in Elderly Dependent Persons
Recruiting NCT04192435 - Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery Phase 4
Recruiting NCT06216080 - Dynamic Full-Field Optical Coherence Tomography for Structural and Microbiological Characterization of Central Venous Catheter-deposited Biofilm in Critically Ill Patients
Enrolling by invitation NCT03924934 - Community-associated Highly-Resistant Enterobacterales
Recruiting NCT06379139 - Dynamic Full-field Optical Coherence Tomography for Structural and Microbiological Characterization of Endotracheal Tube Biofilm in Critically Ill Patients
Recruiting NCT06155747 - Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)
Completed NCT03349268 - Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection N/A
Completed NCT04053257 - Effect of Video Camera Monitoring Feedback on Hand Hygiene Compliance and Infections in NICU N/A
Not yet recruiting NCT03189043 - Controlled Crossover Study of AIONX Antimicrobial Surface for the Prevention of Healthcare-associated Infections Phase 2
Completed NCT05797818 - Red Light Photobiomodulation and Topical Disinfectants Phase 1/Phase 2
Terminated NCT03361085 - Modular Prevention Bundle for Non-ventilator-associated Hospital-acquired Pneumonia (nvHAP) N/A
Completed NCT04770597 - Monitors to Improve Indoor Carbon Dioxide (CO2) Concentrations in the Hospital N/A
Recruiting NCT05612672 - Evaluation of GeoHAI Implementation N/A
Completed NCT04676581 - Risk Benefit Ratio of Hirudotherapy: Retrospective Single-center Study of 37 Cases Over a Period of 9 Years
Recruiting NCT05979545 - EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics Phase 4
Active, not recruiting NCT04312243 - NO Prevention of COVID-19 for Healthcare Providers Phase 2